Comparative assessment of three treatment regimens in patients with superficial mycoses of smooth skin

Kruglova L.S., Mayorov R.Yu.

Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation, Moscow, Russia

Skin mycoses are a significant medical and social problem in the modern world, with approximately every 5th inhabitant of the planet suffering from this infectious disease. In recent years, there has been an increase in the prevalence of pathogenic fungal strains resistant to classical antifungal therapy. This is due to the irrational use of drugs, insufficient patient compliance with treatment, and diagnostic gaps. A rational choice of topical antifungals can significantly reduce the need for systemic drugs and increase the effectiveness of dermatomycosis therapy. The domestic company INTELBIO has developed a combined antifungal cream Mycolept with an additional antipruritic component for the treatment of patients with fungal skin infections. This article describes an open comparative study of Mycolept cream, which contains 1% ciclopirox, climbazole, and polidocanol, versus placebo and sertocanasol.

Keywords

About the Authors

Corresponding author: Roman Yu. Mayorov, Dermatovenerologist, Teaching Assistant at the Department of Dermatovenereology and Cosmetology, Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation, Moscow, Russia; roman1396@bk.ru

Similar Articles